Tissue engineering of musculoskeletal tissues, especially bone and cartilage, is a quickly propelling field. In bone, innovation has fixated on bone unite substitute materials and the improvement of biodegradable scaffolds. Tissue engineering methodologies have included cell and gene therapy. The accessibility of development factors and the growing information base concerning the genetics and regulation of bone formation have generated new materials for tissue-engineering applications. The issues are more perplexing, and the solutions appear more elusive. Innovations in scaffold design and cell culture have improved the prognosis for success. A number of matrices have been tested in vitro and in vivo in preclinical and clinical examinations. These networks can be characterized by their nature.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation